The financial services unit General Electric Company (NYSE:GE), GE Capital has acquired 8 per cent stake in Bangalore, India based Syngene for $23 million, according to a Biocon statement. GE’s move to acquire stake in Syngene, which makes the formulation development and chemistry services firm worth $300m, comes as the Indian services firm is set to list on an as yet unspecified financial market.
Dr Kiran Mazumdar Shaw, Chairman & MD of Biocon Ltd, said that GE Capital’s investment in Biocon’s subsidiary Syngene, confirms their research services business model which has provided consistent value to their partners and other stakeholders. The investment has been made just a few months after GE Healthcare, another unit of US conglomerate bought genomic services CRO, SeqWright, as a step toward building in the personalized medicines space.
Where the stock is moving now?
Shares of General Electric traded up 0.84% during last trading session, closing at $21.59. The share price of GE traded yesterday in a range of $21.45 to $21.77. The company now has a market value of $227.97 billion.
Is current price trend good or bad?
The stock, after recent close, is -1.10% down their SMA 50 and 6.86% off the 52-week high. The worst hit in its 52 week range is $14.68 per share, with $23.18 as its 52 week best price that compares with a latest closing price of $21.59. Its most recent closing price has a distance of -2.05% from SMA20 and is 8.29% up than SMA200.
Now compare performances of this stock in different time periods.
With recent gain, the year-to-date (YTD) performance reflected a 23.58% gain above last year. During the past month the stock dropped -5.93%, bringing three-month performance to +3.75% and six-month performance to +13.57%.
How much risky is this stock?
For this company, beta value at 1.62 represents it is more volatile to the shift in the market. If we take a look on its volatility, 1.64% was seen in a week and for the month it was 1.52%.
Not enough? See what Wall Street analysts think about this company.
For the stock, mean recommendation this week is 2.0. Sharing price target summary; nearly 14 brokerages have a mean PT as $24.86 and median PT of $24.00 while the highest price target set by those rating agencies was $30.00 and lowest PT was $23.00.